Short of breath and dying: State of the science on opioid agents for the palliation of refractory dyspnea in older adults

Journal of Gerontological Nursing

Volumn 39, Issue 2, 2013, Pages 43-52

  Lowey, Susan E ^a   Powers, Bethel Ann ^b   Xue, Ying ^b  

^a The John A Hartford Foundation   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874702411     PISSN: 00989134     EISSN: None     Source Type: Journal    
DOI: 10.3928/00989134-20121204-06     Document Type: Article

References (37)

1. Abernathy, A.P., Currow, D.C., Frith, P., Fazekas, B.S., Mchugh, A., & Bui, C. (2003). Randomized, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ, 327, 523-528.
2. Allen, S., Raut, S., Woollard, J., & Vassallo, M. (2005). Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliative Medicine, 19, 128-130.
3. Blinderman, C.D., Homel, P., Billings, J.A., Tennstedt, S., & Portenoy, R.K. (2009). Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. Journal of Pain and Symptom Management, 38, 115-123.
4. Bruera, E., Sala, R., Spruyt, O., Palmer, L., Zhang, T., & Willey, J. (2005). Nebulized versus subcutaneous morphine for patients with cancer dyspnea: A preliminary study. Journal of Pain and Symptom Management, 29, 613-618. doi:10.1016/j.jpainsymman.2004.08.016
5. Charles, M.A., Reymond, L., & Israel, F. (2008). Relief of incident dyspnea in palliative cancer patients: A pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline. Journal of Pain and Symptom Management, 36, 29-38.
6. Chau, D.L., Walker, V., Pai, L., & Cho, L.M. (2008). Opiates and elderly: Use and side effects. Clinical Interventions in Aging, 3, 273-278. doi:10.2147/CIA.S1847
7. Clemens, K.E., & Klaschik, E. (2007). Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. Journal of Pain and Symptom Management, 33, 473-481. doi:1016/j.jpainsymman.2006.09.015
8. Clemens, K.E., & Klaschik, E. (2008). Morphine in the management of dyspnoea in ALS: A pilot study. European Journal of Neurology, 15, 445-450. doi:10.1111/j.1468-1331.2008.02102.x
9. Clemens, K.E., Quednau, I., & Klaschik, E. (2008). Is there a higher risk of respiratory depression in opioid-naïve palliative care patients during symptomatic therapy of dyspnea with strong opioids? Journal of Palliative Medicine, 11, 204-216.
10. Clemens, K.E., Quednau, I., & Klaschik, E. (2009). Use of oxygen and opioids in the palliation of dyspnea in hypoxic and non-hypoxic palliative care patients: A prospective study. Support Care in Cancer, 17, 367-377.
11. Connor, S.R., Pyenson, B., Fitch, K., Spence, C., & Iwasaki, K. (2007). Comparing hospice and non-hospice patient survival among patients who die within a three-year window. Journal of Pain and Symptom Management, 33, 238-246.
12. Coyne, P.J., Viswanathan, R., & Smith, T.J. (2002). Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. Journal of Pain and Symptom Management, 23, 157-160. doi:10.1016/S0885-3924(01)00391-8
13. Currow, D.C., Mcdonald, C., Oaten, S., Kenny, B., Allcroft, P., Frith, P., Abernathy, A.P. (2011). Once-daily opioids for chronic dyspnea: A dose increment and pharmacovigilance study. Journal of Pain and Symptom Management, 42, 388-399.
14. Currow, D.C., Plummer, J., Frith, P., & Abernathy, A.P. (2007). Can we predict which patients with refractory dyspnea will respond to opioids? Journal of Palliative Medicine, 10, 1031-1036.
15. Elkington, H., White, P., Addington-Hall, J., Higgs, R., & Edmonds, P. (2005). The healthcare needs of chronic obstructive pulmonary patients in the last year of life. Palliative Medicine, 19, 485-491. doi:10.1191/0269216305pm1056oa
16. Garrard, J. (2007). Health sciences literature review made easy: The Matrix Method. Sudbury, MA: Jones & Bartlett.
17. Gauna, A.A., Kang, S.K., Lawhon-Triano, M., Swatko, E.R., & Vanston, V.J. (2008). Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: An observational case series. Journal of Palliative Medicine, 11, 643-648. doi:10.1089/jpm.2008.9922.
18. Hawker, S., Payne, S., Kerr, C., Hardey, M., & Powell, J. (2002). Appraising the evidence: Reviewing disparate data systematically. Qualitative Health Research, 12, 1284-1299. doi:10.1177/1049732302238251
19. Hu, W.Y., Chiu, T.Y., Cheng, S.Y., & Chen, C.Y. (2004). Morphine for dyspnea control in terminal cancer patients: Is it appropriate in Taiwan? Journal of Pain and Symptom Management, 28, 356-363.
20. Jennings, A.L., Davies, A.N., Higgins, J.P.T., Anzures-Cabrera, J., & Broadley, K.E. (2001). Opioids for the palliation of breathlessness in advanced disease and terminal illness (Article No. CD002066). Cochrane Database of Systematic Reviews, Issue 3. doi:10.1002/14651858.CD002066
21. Johnson, M.J., Mcdonagh, T.A., Harkness, A., Mckay, S.E., & Dargie, H.J. (2002). Morphine for the relief of breathlessness in patients with chronic heart failure: A pilot study. European Journal of Heart Failure, 4, 753-756. doi:10.1016/S1388-9842(02)00158-7
22. Lanken, P.N., Terry, P.B., Delisser, H.M., Fahy, B.F., Hansen-Flaschen, J., Heffner, J.E., Yankaskas, J.R. (2008). An official American Thoracic Society clinical policy statement: Palliative care for patients with respiratory diseases and critical illnesses. American Journal of Respiratory Critical Care Medicine, 177, 912-927. doi:10.1164/rccm.200605-587ST
23. Lunney, J.R., Lynn, J., & Hogan, C. (2002). Profiles of older Medicare decedents. Journal of the American Geriatrics Society, 50, 1108-1112. doi:10.1046/j.1532-5415.2002.50268.x
24. Mahler, D.A. (2006). Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society, 3, 234-238. doi:10.1513/pats.200509-103SF
25. Mahler, D.A., Murray, J.A., Waterman, L.A., Ward, J., Kraemer, W.J., Zhang, X., Baird, J.C. (2009). Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. European Respiratory Journal, 33, 771-777.
26. Navigante, A.H., Castro, M.A., & Cerchietti, L.C. (2010). Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated. Journal of Pain and Symptom Management, 39, 820-830.
27. Navigante, A.H., Cerchietti, L.C., Castro, M.A., Lutteral. M.A., & Cabalar, M.E. (2006). Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. Journal of Pain and Symptom Management, 31, 38-47. doi:10.1016/j.jpainsymman.2009.10.003
28. Nordgren, L., & Sorensen, S. (2003). Symptoms experienced in the last six months of life in patients with end-stage heart failure. European Journal of Cardiovascular Nursing, 2, 213-217.
29. Oxberry, S.G., Torgerson, D.J., Bland, J.M., Clark, A.L., Cleland, J.G., & Johnson, M.J. (2011). Short-term opioids for breathlessness in stable chronic heart failure: A randomized controlled trial. European Journal of Heart Failure, 13, 1006-1012.
30. Portenoy, R.K., Sibirceva, U., & Smout, R. (2006). Opioid use and survival at the end of life: A survey of a hospice population. Journal of Pain and Symptom Management, 32, 352-340. doi:10.1016/j.jpainsymman.2006.08.003
31. Powers, B.A., Norton, S.A., Schmitt, M.H., Quill, T.E., & Metzger, M. (2011). Meaning and practice of palliative care for hospitalized older adults with life limiting illnesses. Journal of Aging Research. Retrieved from http://www.hindawi.com/journals/jar/2011/406164. doi:10.4061/2011/406164
32. Setoguchi, S., Glynn, R.J., Stedman, M., Flavell, C.M., Levin, R., & Stevenson, L.W. (2010). Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. American Heart Journal, 160, 139-144. doi:10.1016/j.ahj.2010.03.038
33. Smith, H.S. (2009). Opioid metabolism. Mayo Clinical Proceedings, 84, 613-624.
34. Thomas, J.R., & Von Gunten, C.F. (2003). Management of dyspnea. Journal of Supportive Oncology, 1, 23-34.
35. Walke, L.M., Byers, A.L., Tinetti, M.E., Dubin, J.A., Mccorkle, R., & Fried, T.R. (2007). Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Archives of Internal Medicine, 167, 2503-2508. doi:10.1001/archinte.167.22.2503
36. Wiese, C.H., Bartels, U.E., Graf, B.M., & Hanekop, G.G. (2009). Out-of-hospital opioid therapy of palliative care patients with "acute dyspnoea": A retrospective multicenter investigation. Journal of Opioid Management, 5, 115-122.
37. Williams, S.G., Wright, D.J., Marshall, P., Reese, A., Tzeng, B.H., Coats, A.J., & Tan, L.B. (2003). Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart, 89, 1085-1086. doi:10.1136/heart.89.9.1085